Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Peritoneal carcinomatosis in non-small-cell lung cancer: retrospective multicentric analysis and literature review.

Abbate MI, Cortinovis DL, Tiseo M, Vavalà T, Cerea G, Toschi L, Canova S, Colonese F, Bidoli P.

Future Oncol. 2019 Mar;15(9):989-994. doi: 10.2217/fon-2018-0469. Epub 2019 Jan 25. Review.

PMID:
30681378
2.

Activity of EGFR TKIs in Caucasian Patients With NSCLC Harboring Potentially Sensitive Uncommon EGFR Mutations.

Passaro A, Prelaj A, Bonanno L, Tiseo M, Tuzi A, Proto C, Chiari R, Rocco D, Genova C, Sini C, Cortinovis D, Pilotto S, Landi L, Bennati C, Camerini A, Toschi L, Putzu C, Cerea G, Spitaleri G, Cappuzzo F, de Marinis F.

Clin Lung Cancer. 2019 Mar;20(2):e186-e194. doi: 10.1016/j.cllc.2018.11.005. Epub 2018 Nov 20.

PMID:
30563752
3.

TRKA expression and NTRK1 gene copy number across solid tumours.

Mauri G, Valtorta E, Cerea G, Amatu A, Schirru M, Marrapese G, Fiorillo V, Recchimuzzo P, Cavenago IS, Bonazzina EF, Motta V, Lauricella C, Veronese S, Tosi F, Maiolani M, Rospo G, Truini M, Bonoldi E, Christiansen J, Potts SJ, Siena S, Sartore-Bianchi A.

J Clin Pathol. 2018 Oct;71(10):926-931. doi: 10.1136/jclinpath-2018-205124. Epub 2018 May 25.

PMID:
29802225
4.

Pooled Analysis of Clinical Outcome of Patients with Chemorefractory Metastatic Colorectal Cancer Treated within Phase I/II Clinical Studies Based on Individual Biomarkers of Susceptibility: A Single-Institution Experience.

Sartore-Bianchi A, Amatu A, Bonazzina E, Stabile S, Giannetta L, Cerea G, Schiavetto I, Bencardino K, Funaioli C, Ricotta R, Cipani T, Schirru M, Gambi V, Palmeri L, Carlo-Stella G, Rusconi F, Di Bella S, Burrafato G, Cassingena A, Valtorta E, Lauricella C, Pazzi F, Gambaro A, Ghezzi S, Marrapese G, Tarenzi E, Veronese S, Truini M, Vanzulli A, Siena S.

Target Oncol. 2017 Aug;12(4):525-533. doi: 10.1007/s11523-017-0505-6.

5.

Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1).

Drilon A, Siena S, Ou SI, Patel M, Ahn MJ, Lee J, Bauer TM, Farago AF, Wheler JJ, Liu SV, Doebele R, Giannetta L, Cerea G, Marrapese G, Schirru M, Amatu A, Bencardino K, Palmeri L, Sartore-Bianchi A, Vanzulli A, Cresta S, Damian S, Duca M, Ardini E, Li G, Christiansen J, Kowalski K, Johnson AD, Patel R, Luo D, Chow-Maneval E, Hornby Z, Multani PS, Shaw AT, De Braud FG.

Cancer Discov. 2017 Apr;7(4):400-409. doi: 10.1158/2159-8290.CD-16-1237. Epub 2017 Feb 9.

6.

Efficacy and safety of rechallenge treatment with gefitinib in patients with advanced non-small cell lung cancer.

Cappuzzo F, Morabito A, Normanno N, Bidoli P, Del Conte A, Giannetta L, Montanino A, Mazzoni F, Buosi R, Burgio MA, Cerea G, Chiari R, Cortinovis D, Finocchiaro G, Foltran L, Migliorino MR, Tiseo M, Ferrari S, De Marinis F.

Lung Cancer. 2016 Sep;99:31-7. doi: 10.1016/j.lungcan.2016.06.008. Epub 2016 Jun 14.

PMID:
27565910
7.

Novel CAD-ALK gene rearrangement is drugable by entrectinib in colorectal cancer.

Amatu A, Somaschini A, Cerea G, Bosotti R, Valtorta E, Buonandi P, Marrapese G, Veronese S, Luo D, Hornby Z, Multani P, Murphy D, Shoemaker R, Lauricella C, Giannetta L, Maiolani M, Vanzulli A, Ardini E, Galvani A, Isacchi A, Sartore-Bianchi A, Siena S.

Br J Cancer. 2015 Dec 22;113(12):1730-4. doi: 10.1038/bjc.2015.401. Epub 2015 Dec 3.

8.

Eosinophilic myocarditis: a paraneoplastic event.

Ammirati E, Stucchi M, Brambatti M, Spanò F, Bonacina E, Recalcati F, Cerea G, Vanzulli A, Frigerio M, Oliva F.

Lancet. 2015 Jun 20;385(9986):2546. doi: 10.1016/S0140-6736(15)60903-5. No abstract available.

PMID:
26122067
9.

Phase II randomized study of vandetanib plus gemcitabine or gemcitabine plus placebo as first-line treatment of advanced non-small-cell lung cancer in elderly patients.

Gridelli C, Novello S, Zilembo N, Luciani A, Favaretto AG, De Marinis F, Genestreti G, Crinò L, Grossi F, Caffo O, Ferraù F, Cruciani G, Brandes AA, Galetta D, Barni S, Fasola G, Cerea G, Ferrari S, Iannacone C, Ciardiello F.

J Thorac Oncol. 2014 May;9(5):733-7. doi: 10.1097/JTO.0000000000000120.

10.

Sorafenib in combination with erlotinib or with gemcitabine in elderly patients with advanced non-small-cell lung cancer: a randomized phase II study.

Gridelli C, Morgillo F, Favaretto A, de Marinis F, Chella A, Cerea G, Mattioli R, Tortora G, Rossi A, Fasano M, Pasello G, Ricciardi S, Maione P, Di Maio M, Ciardiello F.

Ann Oncol. 2011 Jul;22(7):1528-34. doi: 10.1093/annonc/mdq630. Epub 2011 Jan 6.

PMID:
21212155
11.

Rationale and clinical results of multi-target treatments in oncology.

Sartore-Bianchi A, Ricotta R, Cerea G, Maugeri MR, Siena S.

Int J Biol Markers. 2007 Jan-Mar;22(1 Suppl 4):S77-87. Review.

PMID:
17520585
12.

Rationale and clinical results of multi-target treatments in oncology.

Sartore-Bianchi A, Ricotta R, Cerea G, Maugeri MR, Siena S.

Int J Biol Markers. 2007 S4 - Jan-Mar;22(4):77-87. doi: 10.5301/JBM.2008.4310.

PMID:
28207118
13.

Pegfilgrastim: current and future perspectives in the treatment of chemotherapy-induced neutropenia.

Ricotta R, Cerea G, Schiavetto I, Maugeri MR, Pedrazzoli P, Siena S.

Future Oncol. 2006 Dec;2(6):667-76. Review.

PMID:
17155894
14.

Cetuximab for treatment of metastatic colorectal cancer.

Cerea G, Ricotta R, Schiavetto I, Maugeri MR, Sartore-Bianchi A, Moroni M, Artale S, Siena S.

Ann Oncol. 2006 Jun;17 Suppl 7:vii66-7.

PMID:
16760297
15.

Anti-EGFR monoclonal antibodies in the treatment of non-small cell lung cancer.

Sartore-Bianchi A, Cerea G, Schiavetto I, Giannetta L, Ricotta R, Maugeri MR, Moroni M, Marrapese G, Siena S.

Ann Oncol. 2006 Mar;17 Suppl 2:ii49-51. Review. No abstract available.

PMID:
16608982
16.

Treatment of metastatic neuroendocrine carcinomas based on WHO classification.

Artale S, Giannetta L, Cerea G, Maggioni D, Pedrazzoli P, Schiavetto I, Napolitano M, Veronese S, Bramerio E, Gambacorta M, Vanzulli A, Pisconti S, Pugliese R, Siena S.

Anticancer Res. 2005 Nov-Dec;25(6C):4463-9. Erratum in: Anticancer Res. 2006 May-Jun;26(3a):2187. Maggioni, Dario [added].

17.

Iron supplement in cancer patients receiving erythropoietin.

Pedrazzoli P, Tullio C, Cerea G, Siena S.

J Clin Oncol. 2004 Nov 1;22(21):4428; author reply 4428-9. No abstract available.

PMID:
15514387

Supplemental Content

Support Center